Flash FinanceUS
After hours S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · GERON CORP (GERN)

Geron Q2 2026 RYTELO revenue rises to $57.5 million; full-year guidance reaffirmed

Positive Impact 3 of 5 earnings Written later

Geron reported second-quarter 2026 product revenue of $57.5 million, up from $49.0 million a year earlier, and net loss of $16.7 million, or $0.02 per share, versus $16.4 million a year earlier. The company reiterated its 2026 RYTELO net product revenue guidance of $220 million to $240 million and operating expense guidance of $230 million to $240 million, and ended the quarter with $326.9 million in cash and marketable securities.

Key points

  • Q2 2026 product revenue, net, was $57.5 million versus $49.0 million in Q2 2025.
  • Cost of goods sold rose to $9.2 million from $1.2 million, mainly due to non-cash inventory-related expenses.
  • 2026 guidance reiterated: RYTELO net product revenue of $220 million to $240 million and total operating expenses of $230 million to $240 million.
  • Cash, cash equivalents, restricted cash and marketable securities were $326.9 million at June 30, 2026, down from $341.0 million at March 31, 2026.

The filing

CompanyGERON CORP (GERN)
Form8-K, current report
Filed with the SECAug 6, 2026, 6:05 AM ET
Accession number0001193125-26-336508

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 06, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.